Champlain Investment Partners’s Bruker BRKR Stock Holding History
Bought
Maintained
Sold
Other funds holding BRKR
OAG
PCA
SC
SHCM
Champlain Investment Partners's BRKR Position: Q2 2026 in Review
Champlain Investment Partners reduced its Bruker (BRKR) stake by 41% in Q2 2026, selling an estimated $11.6M and leaving 355,746 shares worth $21.4M. The position accounts for 0.55% of the portfolio, ranked #88.
Champlain Investment Partners first reported a position in BRKR in Q2 2025 and has held it in 5 quarters since. The position peaked at $35.4M in Q4 2025. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.
- Champlain Investment Partners held 355,746 shares of Bruker worth $21.4M as of Q2 2026.
- Champlain Investment Partners sold 249,369 Bruker shares in Q2 2026, an estimated $11.6M.
- Bruker made up 0.55% of Champlain Investment Partners's portfolio in Q2 2026, its #88 holding.
- Champlain Investment Partners first reported a position in Bruker in Q2 2025 and has held it in 5 quarters since.
- Champlain Investment Partners's Bruker position peaked at $35.4M in Q4 2025.
- 417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.
Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.